Liječnički vjesnik, Vol. 138 No. 7-8, 2016.
Stručni rad
CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part III: neuroendocrine neoplasms, hepatocellular carcinoma, pancreatic cancer, cancer of the bile ducts
Natalija Dedić Plavetić
Renata Kelemenić Dražin
Renata Dobrila Dintinjana
Mladen Radić
Juraj Prejac
Zrinka Mišetić Dolić
Mirjana Pavlović
Mate Škegro
Robert Šeparović
Damir Vrbanec
Sažetak
The treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a specific oncological treatment further follow-up is being managed mostly by the oncologists, but the role of the general practitioners becomes more important every day and therefore should be precisely defined. Nowadays, most of the existing follow-up guidelines are not based on prospective studies, but on the experts opinion of individual oncological centers or specialists. The aim of the Croatian Society of Medical Oncology (CSMO) with these recommendations is to standardize and rationalize the diagnostic procedures algorithm in the follow-up of oncological patients after primary treatment, in patients with neuroendocrine neoplasms, hepatocellular carcinoma, pancreatic cancer and cancer of the bile ducts.
Ključne riječi
Neuroendocrine tumors – diagnosis, pathology, therapy; Carcinoma, hepatocellular – diagnosis, therapy; Liver neoplasms – diagnosis, therapy; Pancreatic neoplasms – diagnosis, pathology, therapy; Adenocarcinoma – diagnosis, therapy; Gallbladder neoplasms – diagnosis, therapy; Bile duct neoplasms – diagnosis, therapy; Medical oncology – standards; Practice guidelines as topic – standards; Follow-up studies; Croatia
Hrčak ID:
172868
URI
Datum izdavanja:
5.9.2016.
Posjeta: 4.157 *